Novel cell culture systems for the hepatitis C virus

Citation
R. Bartenschlager et V. Lohmann, Novel cell culture systems for the hepatitis C virus, ANTIVIR RES, 52(1), 2001, pp. 1-17
Citations number
103
Categorie Soggetti
Microbiology
Journal title
ANTIVIRAL RESEARCH
ISSN journal
01663542 → ACNP
Volume
52
Issue
1
Year of publication
2001
Pages
1 - 17
Database
ISI
SICI code
0166-3542(200110)52:1<1:NCCSFT>2.0.ZU;2-O
Abstract
Infections with the hepatitis C virus (HCV) are a major cause of acute and chronic liver disease. The high prevalence of the virus, the insidious cour se of the disease and the poor prognosis for long-term persistent infection make this pathogen a serious medical and socioeconomical problem. The iden tification of the viral genome similar to 10 years ago rapidly led to the d elineation of the genomic organization and the structural and biochemical c haracterization of several virus proteins. However, studies of the viral li fe cycle as well as the development of antiviral drugs have been difficult because of the lack of a robust and reliable cell culture system. Numerous attempts have been undertaken in the past few years but only recently a hig hly efficient cell culture model could be developed. This system is based o n the self replication of engineered HCV minigenomes (replicons) in a trans fected human hepatoma cell line. A summary of the various HCV cell culture models with a focus on the replicon system and its use for drug development is described. (C) 2001 Elsevier Science B.V. All rights reserved.